Matlin David J insider trades
Matlin David J has filed 53 Form 4s with the SEC that we hold, for Clene Inc. (CLNN) (Director), TriSalus Life Sciences, Inc. (TLSI) (Director), USWS (Director) and LONE (10% owner). Across all of them we count 28 purchases worth $7.9M and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($216.7K) and 0 sales ($0). The largest single trade was a purchase of 2,871,287 shares of Clene Inc. worth $2.9M, dated 2022-11-02. The first filing on our record is dated 2021-08-05 and the latest 2026-09-18.
Clene Inc. (CLNN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-11-12 | P, purchase reported on Form 4 | 10,000 | $53.7K | 2021-11-15 |
| 2021-11-15 | P, purchase reported on Form 4 | 15,000 | $85.7K | 2021-11-15 |
| 2021-11-16 | P, purchase reported on Form 4 | 20,000 | $105.2K | 2021-11-17 |
| 2021-12-08 | P, purchase reported on Form 4 | 5,000 | $24.6K | 2021-12-10 |
| 2021-12-09 | P, purchase reported on Form 4 | 40,000 | $200.0K | 2021-12-10 |
| 2021-12-10 | P, purchase reported on Form 4 | 15,000 | $73.0K | 2021-12-10 |
| 2022-02-01 | P, purchase reported on Form 4 | 101,352 | $300.0K | 2022-02-02 |
| 2022-03-18 | P, purchase reported on Form 4 | 20,000 | $55.8K | 2022-03-22 |
| 2022-03-21 | P, purchase reported on Form 4 | 35,000 | $101.5K | 2022-03-22 |
| 2022-03-23 | P, purchase reported on Form 4 | 20,000 | $58.8K | 2022-03-25 |
| 2022-03-24 | P, purchase reported on Form 4 | 20,000 | $59.8K | 2022-03-25 |
| 2022-03-28 | P, purchase reported on Form 4 | 10,000 | $31.0K | 2022-03-30 |
| 2022-03-29 | P, purchase reported on Form 4 | 8,648 | $27.9K | 2022-03-30 |
| 2022-04-20 | P, purchase reported on Form 4 | 132,891 | $400.0K | 2022-04-21 |
| 2022-05-16 | P, purchase reported on Form 4 | 181,818 | $400.0K | 2022-05-18 |
| 2022-05-27 | P, purchase reported on Form 4 | 35,000 | $79.5K | 2022-05-27 |
| 2022-06-03 | P, purchase reported on Form 4 | 10,000 | $24.6K | 2022-06-07 |
| 2022-06-06 | P, purchase reported on Form 4 | 50,670 | $130.2K | 2022-06-07 |
| 2022-06-13 | P, purchase reported on Form 4 | 55,000 | $168.3K | 2022-06-14 |
| 2022-06-14 | P, purchase reported on Form 4 | 51,011 | $135.7K | 2022-06-16 |
| 2022-06-15 | P, purchase reported on Form 4 | 45,000 | $119.7K | 2022-06-16 |
| 2022-06-16 | P, purchase reported on Form 4 | 75,000 | $187.5K | 2022-06-21 |
| 2022-06-17 | P, purchase reported on Form 4 | 74,610 | $187.3K | 2022-06-21 |
| 2022-11-02 | P, purchase reported on Form 4 | 2,871,287 | $2.9M | 2022-11-03 |
| 2023-06-16 | P, purchase reported on Form 4 | 1,500,000 | $1.2M | 2023-06-20 |
| 2023-11-10 | P, purchase reported on Form 4 | 250,002 | $102.5K | 2023-11-13 |
| 2024-09-30 | P, purchase reported on Form 4 | 92,307 | $438.5K | 2024-10-02 |
| 2026-01-13 | P, purchase reported on Form 4 | 33,333 | $216.7K | 2026-01-13 |
TriSalus Life Sciences, Inc. (TLSI)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
USWS
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
LONE
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1251956) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms